Pharmaceutical Executive Issue Alert Having trouble viewing this email? Click here
Web Version | Share with a colleague | View Digital Edition | Subscribe
In our January issue of Pharmaceutical Executive
FEATURES

Cover Feature
Pharm Exec’s 2020 Industry Outlook
 Pharm Exec Editors
Pharm Exec’s annual forecast of the key issues facing biopharma leaders in the year ahead taps experts from several areas to uncover the seven new-decade trends to watch.
Download the digital issue

Executive Profile
Sebastian Guth: Paving Bayer’s Future
Lisa Henderson
Led in part by its new head of the Americas business, Sebastian Guth, Bayer went all in in 2019 on expanding pursuits in science and discovery, striking deals with 11 digital health startups and upping investment in disease-detection programs and patient engagement.
Download the digital issue
ADVERTISEMENT
Break Free from Forecast Inaccuracy: How Machine Learning Can Drive Better Quality Commercial Forecasting
Thursday, February 20, 2020 at 11am EST | 8am PST | 4pm GMT | 5pm CET
Register Now
Market Access
Is the Tail Wagging the Dog in Drug Market Entry?
Judith Kulich and Ben Hohn
Three product launch trends driven by emerging biopharma.
Download the digital issue
UK/EU
Pharma’s Brexit Route
 Julian Upton
The path for UK life sciences to factor prominently in transition-period maneuvering.
Download the digital issue
ADVERTISEMENT
Market Pricing Dynamics for the Machine Learning Age
Are You Getting the Insights You Need?
Thursday, March 26, 2019 at 11am EDT |10am CDT |4pm BST |5pm CEST
Register Now

ALSO IN THIS ISSUE
 Sharing the Pricing Stage in 2020
Lisa Henderson
While drug pricing remains a hot topic in the media at large and worthy of continuous exploration, we shift away in our latest pharma trends report, instead spotlighting seven key themes that we think are a bit less unpredictable in the months ahead …Read more

Politics and Pricing to Shape Pharma Policy in 2020
Jill Wechsler
Challenges will mount to established models for researching, developing, and marketing new therapies …Read more

A Happy New Year for European Pharma Policy?
Reflector
What to make of new momentum in advancing health agenda …Read more

ADVERTISEMENT
Three Key Critical Considerations Before Embarking on Decentralized Trials
Tuesday, January 28, 2020 at 11am EST | 8am PST | 4pm GMT | 5pm CET
Register Now
 
Download the
issue:
 
image
 

WEBCASTS
Market Pricing Dynamics for the Machine Learning Age - Are You Getting the Insights You Need?
Break Free from Forecast Inaccuracy: How Machine Learning Can Drive Better Quality Commercial Forecasting
Three Key Critical Considerations Before Embarking on Decentralized Trials
Order-To-Cash Management Fundamentals to Increase Profitability and Reduce Risk
A Modern Approach to Global Growth & Compliance in Life Sciences: A Story of Digitalization at Boehringer Ingelheim
Launching Medical Devices in the Japanese Market: How to Navigate Regulatory and Reimbursement Approval
Japan Oncology Market: Best in Class Practices for Advancing Patient Outcomes

Pharmaceutical Executive is free to qualified subscribers. To subscribe, click here.

Click here to contact the Pharmaceutical Executive sales team.
Twitter LinkedIn